NCT05536310View on ClinicalTrials.gov

TAVIS Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease

Not yet recruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

March 31, 2023

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2027

Conditions
Aortic Valve StenosisAortic Valve RegurgitationAortic Valve Stenosis With InsufficiencyConstriction, PathologicAortic Valve DiseaseHeart Valve DiseasesCardiovascular Diseases in Old AgeVentricular Outflow ObstructionAortic Stenosis, Severe
Interventions
DEVICE

Transcatheter Aortic Valve Implantation (TAVI)

TAVI with the JenaValve Trilogy Heart Valve System

Trial Locations (3)

32545

Herz-und Diabeteszentrum NRW Ruhr-Universität Bochum Bad Oeynhausen, Bad Oeynhausen

50937

University Hospital of Cologne Heart Center, Cologne

55131

University Hospital Mainz, Mainz

Sponsors
All Listed Sponsors
lead

JenaValve Technology, Inc.

INDUSTRY

NCT05536310 - TAVIS Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease | Biotech Hunter | Biotech Hunter